β-Amyloid efflux mediated by p-glycoprotein

被引:321
作者
Lam, FC
Liu, RH
Lu, PH
Shapiro, AB
Renoir, JM
Sharom, FJ
Reiner, PB
机构
[1] Univ British Columbia, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1Z3, Canada
[2] Univ British Columbia, Grad Program Neurosci, Vancouver, BC V5Z 1M9, Canada
[3] Univ Guelph, Dept Chem & Biochem, Guelph Waterloo Ctr Grad Work Chem, Guelph, ON, Canada
[4] BC Canc Res Ctr, Vancouver, BC, Canada
[5] URA 1218 CNRS, Chatenay Malabry, France
关键词
ABC transporter; Alzheimer's disease; beta-amyloid; MDR1; membrane; p-glycoprotein;
D O I
10.1046/j.1471-4159.2001.00113.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A large body of evidence suggests that an increase in the brain beta -amyloid (A beta) burden contributes to the etiology of Alzheimer's disease (AD). Much is now known about the intracellular processes regulating the production of A beta, however, less is known regarding its secretion from cells. We now report that p-glycoprotein (p-gp), an ATP-binding cassette (ABC) transporter, is an A beta efflux pump, Pharmacological blockade of p-gp rapidly decrease extracellular levels of A beta secretion. In vitro binding studies showed that addition of synthetic human A beta1-40 and A beta1-42 peptides to hamster mdr1-enriched vesicles labeled with the fluorophore MIANS resulted in saturable quenching, suggesting that both peptides interact directly with the transporter. Finally, we were able to directly measure transport of A beta peptides across the plasma membranes of p-gp enriched vesicles, and showed that this phenomenon was both ATP- and p-gp-dependent. Taken together, our study suggests a novel mechanism of A beta detachment from cellular membranes, and represents an obvious route towards identification of such a mechanism in the brain.
引用
收藏
页码:1121 / 1128
页数:8
相关论文
共 48 条
[1]   Biochemical, cellular, and pharmacological aspects of the multidrug transporter [J].
Ambudkar, SV ;
Dey, S ;
Hrycyna, CA ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :361-398
[2]   Regulated intramembrane proteolysis: A control mechanism conserved from bacteria to humans [J].
Brown, MS ;
Ye, J ;
Rawson, RB ;
Goldstein, JL .
CELL, 2000, 100 (04) :391-398
[3]   GENERATION OF BETA-AMYLOID IN THE SECRETORY PATHWAY IN NEURONAL AND NONNEURONAL CELLS [J].
BUSCIGLIO, J ;
GABUZDA, DH ;
MATSUDAIRA, P ;
YANKNER, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) :2092-2096
[4]   Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities [J].
Citron, M ;
Diehl, TS ;
Gordon, G ;
Biere, AL ;
Seubert, P ;
Selkoe, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (23) :13170-13175
[5]   MULTIDRUG-RESISTANCE GENE (P-GLYCOPROTEIN) IS EXPRESSED BY ENDOTHELIAL-CELLS AT BLOOD-BRAIN BARRIER SITES [J].
CORDONCARDO, C ;
OBRIEN, JP ;
CASALS, D ;
RITTMANGRAUER, L ;
BIEDLER, JL ;
MELAMED, MR ;
BERTINO, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (02) :695-698
[6]  
Croop JM, 1998, METHOD ENZYMOL, V292, P101
[7]   Alzheimer's disease - Etiologies, pathophysiology, cognitive reserve, and treatment opportunities [J].
Cummings, JL ;
Vinters, HV ;
Cole, GM ;
Khachaturian, ZS .
NEUROLOGY, 1998, 51 (01) :S2-S17
[8]   Interaction of combinations of drugs, chemosensitisers, and peptides with the P-glycoprotein multidrug transporter [J].
DiDiodato, G ;
Sharom, FJ .
BIOCHEMICAL PHARMACOLOGY, 1997, 53 (12) :1789-1797
[9]  
DOIGE CA, 1992, BIOCHIM BIOPHYS ACTA, V1109, P161, DOI 10.1016/0005-2736(92)90079-2
[10]   EXPRESSION OF A MULTIDRUG-RESISTANCE GENE IN HUMAN-TUMORS AND TISSUES [J].
FOJO, AT ;
UEDA, K ;
SLAMON, DJ ;
POPLACK, DG ;
GOTTESMAN, MM ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (01) :265-269